{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:17:07Z","timestamp":1794377827376,"version":"4.9.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ajog.2025.01.019","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T12:42:03Z","timestamp":1737463323000},"page":"116.e1-116.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8259-635X","authenticated-orcid":false,"given":"Marisa R.","family":"Imbroane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"LeMoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Nau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.01.019_bib1","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2337\/diacare.28.5.1092","article-title":"Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes","volume":"28","author":"DeFronzo","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2025.01.019_bib2","series-title":"StatPearls. Treasure Island, FL","article-title":"Compare and contrast the glucagon-like Peptide-1 receptor agonists (GLP1RAs)","author":"Latif","year":"2024"},{"key":"10.1016\/j.ajog.2025.01.019_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.metabol.2013.09.010","article-title":"Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells","volume":"63","author":"Lee","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.ajog.2025.01.019_bib4","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/jama.2024.7112","article-title":"Dispensing of glucagon-like Peptide-1 receptor agonists to adolescents and young adults, 2020\u20132023","volume":"331","author":"Lee","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2025.01.019_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s13669-023-00350-1","article-title":"Pharmacologic treatment of obesity in reproductive aged women","volume":"12","author":"Nuako","year":"2023","journal-title":"Curr Obstet Gynecol Rep"},{"key":"10.1016\/j.ajog.2025.01.019_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/humupd\/dmz019","article-title":"The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective","volume":"25","author":"Jensterle","year":"2019","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2025.01.019_bib7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/09513590.2014.975686","article-title":"Exenatide improves ovarian and endometrial injury and preserves ovarian reserve in streptozocin induced diabetic rats","volume":"31","author":"Artunc-Ulkumen","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2025.01.019_bib8","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1210\/en.2014-1978","article-title":"GLP-1 increases preovulatory LH source and the number of mature follicles, as well as synchronizing the onset of puberty in female rats","volume":"156","author":"Outeiri\u00f1o-Iglesias","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2025.01.019_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12902-023-01500-5","article-title":"Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review","volume":"23","author":"Zhou","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ajog.2025.01.019_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/cen.13454","article-title":"Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome","volume":"87","author":"Liu","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2025.01.019_bib11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4158\/EP-2019-0609","article-title":"A retrospective study examining phentermine on preconception weight loss and pregnancy outcomes","volume":"26","author":"Chang","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajog.2025.01.019_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.31083\/j.ceog.2021.03.2331","article-title":"Pregnancy outcomes after inadvertent exposure of anti-obesity drugs during pregnancy","volume":"48","author":"Choi","year":"2021","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.01.019_bib13","series-title":"StatPearls. Treasure Island, FL","article-title":"Tirzepatide","author":"Farzam","year":"2024"},{"key":"10.1016\/j.ajog.2025.01.019_bib14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2025.01.019_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-083550","article-title":"Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services","volume":"14","author":"Dao","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2025.01.019_bib16","first-page":"CD012394","article-title":"Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews","volume":"6","author":"Griffith","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2025.01.019_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/bmb\/ldy035","article-title":"The management of hypertension in women planning for pregnancy","volume":"128","author":"Lu","year":"2018","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ajog.2025.01.019_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011626","article-title":"Does pre-pregnancy BMI determine blood pressure during pregnancy? A prospective cohort study","volume":"6","author":"Savitri","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2025.01.019_bib19","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajog.2025.01.019_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/pubmed\/fdr054","article-title":"Systematic review of discharge coding accuracy","volume":"34","author":"Burns","year":"2012","journal-title":"J Public Health (Oxf)"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:15:45Z","timestamp":1778544945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0002937825000419"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.01.019","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}